Top Stories

Lilly and Amgen partner to manufacture potential coronavirus drugs


Lilly corporate headquarters in Indianapolis, Indiana

Source: Eli Lilly

Eli Lilly on Thursday partnered with Amgen to increase the supply of its experimental Covid-19 antibody treatments, a day after one of Lilly’s drugs was shown to reduce the need for hospitalization.

Through the collaboration, the companies will have the ability to scale up production should one or more of Lilly’s antibody therapies receive regulatory approval, the companies said in a statement.

Antibody treatments work by recognizing and locking onto foreign invaders to prevent infection of healthy cells. Several companies including Regeneron Pharmaceuticals and Vir Biotechnology are also testing antibody treatments for…


IPOs that doubled have poor record after debut

Previous article

Why more married millennials are keeping their finances separate

Next article

You may also like

Leave a Reply

Notify of

More in Top Stories